NBS superfood: a promising adjunctive therapy in critically ill ICU patients with omicron variant of COVID-19

NBS superfood: a promising adjunctive therapy in critically ill ICU patients with omicron variant of COVID-19

Abstract This clinical trial aimed to assess the impact of Nutrition Bio-shield superfood (NBS) on clinical status among critically ill ICU patients suffering from acute respiratory distress syndrome (ARDS) due to the Omicron variant of COVID-19. A total of 400 patients with confirmed Omicron-relate...

Full description

Bibliographic Details
Main Authors: Mehrdad Mosadegh, Aref Khalkhali, Yousef Erfani, Manije Nezamdoost, Seyyed Hamid Hashemi, Farid Azizi Jalilian, Nastaran Ansari, Shahab Mahmoudvand, Mojgan Mamani, Elham Abdoli, Razieh Amini, Gholamreza Kalvandi
Format: Article
Language:English
Published: SpringerOpen 2024-03-01
Series:AMB Express
Subjects:
Nutrition bio-shield
SARS-CoV-2 Omicron variant
COVID-19
Complementary therapies
Respiratory distress syndrome
Online Access:https://doi.org/10.1186/s13568-024-01690-8

Internet

https://doi.org/10.1186/s13568-024-01690-8

Similar Items